Article | Published:

Dietary trehalose enhances virulence of epidemic Clostridium difficile

Nature volume 553, pages 291294 (18 January 2018) | Download Citation


Clostridium difficile disease has recently increased to become a dominant nosocomial pathogen in North America and Europe, although little is known about what has driven this emergence. Here we show that two epidemic ribotypes (RT027 and RT078) have acquired unique mechanisms to metabolize low concentrations of the disaccharide trehalose. RT027 strains contain a single point mutation in the trehalose repressor that increases the sensitivity of this ribotype to trehalose by more than 500-fold. Furthermore, dietary trehalose increases the virulence of a RT027 strain in a mouse model of infection. RT078 strains acquired a cluster of four genes involved in trehalose metabolism, including a PTS permease that is both necessary and sufficient for growth on low concentrations of trehalose. We propose that the implementation of trehalose as a food additive into the human diet, shortly before the emergence of these two epidemic lineages, helped select for their emergence and contributed to hypervirulence.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 45, 109–113 (2013)

  2. 2.

    et al. Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J. Med. Microbiol. 57, 784–789 (2008)

  3. 3.

    , , & Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J. Clin. Microbiol. 48, 2892–2896 (2010)

  4. 4.

    et al. Toxinotype V Clostridium difficile in humans and food animals. Emerg. Infect. Dis. 14, 1039–1045 (2008)

  5. 5.

    et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 47, 1162–1170 (2008)

  6. 6.

    & Community-acquired Clostridium difficile infection: an increasing public health threat. Infect. Drug Resist. 7, 63–72 (2014)

  7. 7.

    et al. Clostridium difficile strains from community-associated infections. J. Clin. Microbiol. 47, 3004–3007 (2009)

  8. 8.

    et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin. Infect. Dis. 56, 1589–1600 (2013)

  9. 9.

    et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc. Natl Acad. Sci. USA 107, 7527–7532 (2010)

  10. 10.

    , , & Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates. Infect. Immun. 82, 2815–2825 (2014)

  11. 11.

    et al. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin. Infect. Dis. 58, 1723–1730 (2014)

  12. 12.

    et al. Emergence and spread of predominantly community- onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012. Euro Surveill. 20, 21059 (2015)

  13. 13.

    , , , & Clostridium difficile ribotype 176 – a predictor for high mortality and risk of nosocomial spread? Anaerobe 40, 35–40 (2016)

  14. 14.

    et al. Distribution of Clostridium difficile PCR ribotypes and high proportion of 027 and 176 in some hospitals in four South Eastern European countries. Anaerobe 42, 142–144 (2016)

  15. 15.

    Trehalose malabsorption causing intolerance to mushrooms. Report of a probable case. Gastroenterology 60, 909–912 (1971)

  16. 16.

    , & Trehalose tolerance test. Its value as a test for malabsorption. Scand. J. Gastroenterol. 8, 657–663 (1973)

  17. 17.

    & Estimation of intestinal trehalase activity from a laxative threshold of trehalose and lactulose on healthy female subjects. Eur. J. Clin. Nutr. 54, 783–788 (2000)

  18. 18.

    Novel functions and applications of trehalose. Pure Appl. Chem. 74, 1263–1269 (2002)

  19. 19.

    et al. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10, R102 (2009)

  20. 20.

    & Clostridium difficile infection. N. Engl. J. Med. 372, 1539–1548 (2015)

  21. 21.

    et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 5, 3114 (2014)

  22. 22.

    et al. Genetic markers for Clostridium difficile lineages linked to hypervirulence. Microbiology 157, 3113–3123 (2011)

  23. 23.

    , & Proline-dependent regulation of Clostridium difficile Stickland metabolism. J. Bacteriol. 195, 844–854 (2013)

  24. 24.

    et al. Expanding the repertoire of gene tools for precise manipulation of the Clostridium difficile genome: allelic exchange using pyrE alleles. PLoS ONE 8, e56051 (2013)

  25. 25.

    & Clostridium difficile has two parallel and essential Sec secretion systems. J. Biol. Chem. 286, 27483–27493 (2011)

  26. 26.

    et al. Rapid and reliable DNA assembly via ligase cycling reaction. ACS Synth. Biol. 3, 97–106 (2014)

  27. 27.

    in Real-time PCR (ed. ) 63–82 (Taylor & Francis, 2006)

  28. 28.

    , , , & Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome 3, 35 (2015)

  29. 29.

    , , & in Clostridium difficile: Methods and Protocols (eds & ) 235–258 (Springer, 2016)

  30. 30.

    A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6, 65–70 (1979)

  31. 31.

    et al. Multilocus sequence typing of Clostridium difficile. J. Clin. Microbiol. 48, 770–778 (2010)

  32. 32.

    , & MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33, 1870–1874 (2016)

  33. 33.

    et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011)

  34. 34.

    , & ProfileGrids solve the large alignment visualization problem: influenza hemagglutinin example. F1000 Res. 2, 2 (2013)

  35. 35.

    , & Mutagenic analysis of the Clostridium difficile flagellar proteins, FliC and FliD, and their contribution to virulence in hamsters. Infect. Immun. 79, 4061–4067 (2011)

  36. 36.

    , , & Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect. Immun. 56, 2299–2306 (1988)

  37. 37.

    , & Transferable tetracycline resistance in Clostridium difficile. Antimicrob. Agents Chemother. 19, 997–1003 (1981)

Download references


This work was supported by the National Institutes of Health (U01AI124290-01 and 5U19AI09087202). We thank the members of the Ostomy Association of Greater Lansing for anonymously donating samples, and D. Lyras for the RT244 strains. We thank V. Young, D. Mills, J. Walter and M. Costa-Mattioli for comments on the manuscript.

Author information


  1. Baylor College of Medicine, Department of Molecular Virology and Microbiology, One Baylor Plaza, Houston, Texas 77030, USA

    • J. Collins
    • , H. Danhof
    • , J. M. Auchtung
    •  & R. A. Britton
  2. University of Oregon, Institute for Molecular Biology, 1318 Franklin Boulevard, Eugene, Oregon 97403, USA

    • C. Robinson
  3. Leiden University Medical Centre, Department of Medical Microbiology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands

    • C. W. Knetsch
    •  & H. C. van Leeuwen
  4. Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK

    • T. D. Lawley


  1. Search for J. Collins in:

  2. Search for C. Robinson in:

  3. Search for H. Danhof in:

  4. Search for C. W. Knetsch in:

  5. Search for H. C. van Leeuwen in:

  6. Search for T. D. Lawley in:

  7. Search for J. M. Auchtung in:

  8. Search for R. A. Britton in:


Concept and design of study: R.A.B., J.M.A., J.C. and C.R. Experiments: C. difficile growth, J.C. and C.R.; identification of L172I SNP and comparative analysis, C.R. and J.C.; treA RT–qPCR, H.D.; mouse infection model, J.C.; genetic manipulation of C. difficile strains, J.C. and C.R.; identification of RT078 trehalose insertion, C.W.K., H.C.L. and T.D.L.; faecal minibioreactor competitions, J.M.A.; spontaneous C. difficile mutant identification, H.D.; analysis, J.C., C.R., H.D., J.M.A. and R.B. The manuscript was drafted by J.C., J.M.A., and R.A.B., and revised by all authors.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to R. A. Britton.

Reviewer Information Nature thanks J. Ballard, E. Pamer and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Supplementary information

About this article

Publication history





Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.